Keywords: sanofi, pasteur, h5n1, vacc, shows, broad, anti-infective

Sanofi Pasteur's H5N1 vacc shows broad anti-infective properties

Article | 23 October 2006

Print This

Sanofi Pasteur, the vaccines business of French drug major Sanofi-Aventis says that its H5N1 pre-pandemic vaccine induces antibodies that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in